Singapore markets closed
Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,857.46 -19.59 (-0.25%) Bitcoin USD
64,609.00 +1,144.68 (+1.80%) CMC Crypto 200
1,383.30 +70.67 (+5.70%)
BioNexus Gene Lab Corp. (BGLC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 10:15AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 14.84M |
| Enterprise value | 9.04M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.36 |
| Price/book (mrq) | 1.54 |
| Enterprise value/revenue | 0.93 |
| Enterprise value/EBITDA | -3.64 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 157.27% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 9.4900 |
| 52-week low 3 | 0.0800 |
| 50-day moving average 3 | 0.7324 |
| 200-day moving average 3 | 0.8802 |
Share statistics
| Avg vol (3-month) 3 | 1.56M |
| Avg vol (10-day) 3 | 369.82k |
| Shares outstanding 5 | 17.67M |
| Implied shares outstanding 6 | 17.67M |
| Float 8 | 9.96M |
| % held by insiders 1 | 64.38% |
| % held by institutions 1 | 0.59% |
| Shares short (28 Mar 2024) 4 | 43.36k |
| Short ratio (28 Mar 2024) 4 | 0.15 |
| Short % of float (28 Mar 2024) 4 | 0.25% |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.24% |
| Shares short (prior month 29 Feb 2024) 4 | 50.31k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -26.91% |
| Operating margin (ttm) | -16.90% |
Management effectiveness
| Return on assets (ttm) | -16.10% |
| Return on equity (ttm) | -32.21% |
Income statement
| Revenue (ttm) | 9.77M |
| Revenue per share (ttm) | 0.62 |
| Quarterly revenue growth (yoy) | -20.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -2.51M |
| Net income avi to common (ttm) | -2.63M |
| Diluted EPS (ttm) | -0.1800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 5.93M |
| Total cash per share (mrq) | 0.34 |
| Total debt (mrq) | 133.4k |
| Total debt/equity (mrq) | 1.38% |
| Current ratio (mrq) | 4.93 |
| Book value per share (mrq) | 0.55 |
Cash flow statement
| Operating cash flow (ttm) | -1.3M |
| Levered free cash flow (ttm) | -276.39k |
© 2024 Yahoo. All rights reserved.